oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Atofab

Out-of-specification results for atomoxetine content and non-uniform capsule mass caused by manufacturing defects and changed API particle properties. Potential effects: reduced efficacy of the medicine.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

App Store Google Play
Atofab
Risk Level
Medium
Manufacturer
G.L. Pharma GmbH z siedzibą w Austrii
Batch Number
F06874
EAN Code
09008732012231
Recall Date
20.09.2024
Category
Medicines & supplements
View official statement

Important Information

What You Should Know

Recommendations

Do not use products from batches E01580 and F06874; check the batch number; return the product to the pharmacy or the marketing authorisation holder; consult a doctor or pharmacist if in doubt.

Actions Taken

Withdrawal from the national market of the specified batches; prohibition of placing these batches on the market; decision given immediate enforceability; prior suspension of distribution by decision ...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: Out-of-specification results for atomoxetine content and non-uniform capsule mass caused by manufacturing defects and changed API particle properties. Potential effects: reduced efficacy of the medicine.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: F06874

Related

Other Recalled Products

Lorafen

Lorafen

06.02.2026
Carmustine Accord

Carmustine Accord

03.02.2026
Taromentin

Taromentin

30.01.2026
Plerixafor MSN

Plerixafor MSN

29.01.2026
Zoledronic Acid Noridem

Zoledronic Acid Noridem

29.01.2026